About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Rheumatoid Arthritis Wins A Couple of Rounds | Main | Asking the Tough Questions: Doomsday in the Clinic »

December 13, 2012

Don't Let the Art Director Draw Your Molecules

Email This Entry

Posted by Derek

This is a lesson that everyone should have learned many times before, but those colorful atoms are just so. . .colorful and everything. If anyone knows what element is supposed to be colored "silvery purple", See Arr Oh would like to hear from you.

Comments (6) + TrackBacks (0) | Category: Chemical News


1. Hap on December 13, 2012 9:56 AM writes...

I wonder how you manage to get a Texas carbon model, either in a drawing program or in a physical model.

If you use technical depictions to look pretty while showing how technologically competent the company you work for is, then you should expect criticism from people who actually understand it if it makes no sense. On the other hand, if neither your management or your customers can tell if the picture makes sense, then a nonsensical picture probably is an accurate description of your company's technical prowess.

Permalink to Comment

2. Anon on December 13, 2012 10:32 AM writes...


"a nonsensical picture probably is an accurate description of your company's technical prowess"

So, so true...

Permalink to Comment

3. Secondaire on December 13, 2012 11:18 AM writes...

I like how the thing seems to have chlorine everywhere. My first knee-jerky reaction was "S-Cl" What is this, a Swern reagent? (Wrong oxidation state; point still stands.)

Permalink to Comment

4. Helical_Investor on December 13, 2012 11:47 AM writes...

Nice to see they incorporated the molecular shadow. I expect this was for the holistic crowd.


Permalink to Comment

5. O'Reilly Science Art on December 13, 2012 6:01 PM writes...

As a science illustrator with a PhD in biological chemistry, I wish I could turn this into an ad campaign. (As a part-time adjunct chemistry professor, it just makes me sad.)

Permalink to Comment

6. anonymouse on December 13, 2012 7:04 PM writes...

Who knows, maybe this IS the evasive cure to Alzheimers.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry